GAG
AGN

GM Advisory Group’s Allergan plc AGN Stock Holding History

GM Advisory Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,549
Closed -$983K – 192
2020
Q1 		$983K Buy
+5,549
New +$1.04M 0.27% 50

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

GM Advisory Group's AGN Position: Q2 2020 in Review

GM Advisory Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,549 shares — an estimated $983K sold.

GM Advisory Group first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $983K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • GM Advisory Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • GM Advisory Group sold 5,549 Allergan plc shares in Q2 2020, an estimated $983K.
  • GM Advisory Group first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • GM Advisory Group's Allergan plc position peaked at $983K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on GM Advisory Group's 13F filing for Q2 2020, filed 13 Aug 2020.